IL34552A - תכשירי רוקחות המכילים )-( )ציס-1,2-אפאוקסיפרופיל(- פוספונט - Google Patents

תכשירי רוקחות המכילים )-( )ציס-1,2-אפאוקסיפרופיל(- פוספונט

Info

Publication number
IL34552A
IL34552A IL34552A IL3455270A IL34552A IL 34552 A IL34552 A IL 34552A IL 34552 A IL34552 A IL 34552A IL 3455270 A IL3455270 A IL 3455270A IL 34552 A IL34552 A IL 34552A
Authority
IL
Israel
Prior art keywords
cis
epoxypropyl
phosphonate
calcium
suspension
Prior art date
Application number
IL34552A
Other languages
English (en)
Other versions
IL34552A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL34552A0 publication Critical patent/IL34552A0/xx
Publication of IL34552A publication Critical patent/IL34552A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL34552A 1969-06-02 1970-05-19 תכשירי רוקחות המכילים )-( )ציס-1,2-אפאוקסיפרופיל(- פוספונט IL34552A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82978569A 1969-06-02 1969-06-02

Publications (2)

Publication Number Publication Date
IL34552A0 IL34552A0 (en) 1970-07-19
IL34552A true IL34552A (he) 1973-02-28

Family

ID=25255551

Family Applications (1)

Application Number Title Priority Date Filing Date
IL34552A IL34552A (he) 1969-06-02 1970-05-19 תכשירי רוקחות המכילים )-( )ציס-1,2-אפאוקסיפרופיל(- פוספונט

Country Status (13)

Country Link
US (1) US3678163A (he)
BE (1) BE750811A (he)
CA (1) CA931077A (he)
DE (1) DE2026740A1 (he)
DK (1) DK124989B (he)
FI (1) FI47961C (he)
FR (1) FR2051568B1 (he)
GB (1) GB1263654A (he)
IE (1) IE34331B1 (he)
IL (1) IL34552A (he)
NL (1) NL7006857A (he)
SE (1) SE370865B (he)
ZA (1) ZA703677B (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
DE2522081A1 (de) * 1975-05-17 1976-11-25 Boehringer Mannheim Gmbh Antibiotisch wirksames praeparat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3351527A (en) * 1964-10-01 1967-11-07 American Home Prod Stabilized benzathine penicillin compositions

Also Published As

Publication number Publication date
FI47961B (he) 1974-01-31
SE370865B (he) 1974-11-04
FI47961C (fi) 1974-05-10
IL34552A0 (en) 1970-07-19
DK124989B (da) 1972-12-18
BE750811A (fr) 1970-11-23
GB1263654A (en) 1972-02-16
FR2051568A1 (he) 1971-04-09
ZA703677B (en) 1972-01-26
NL7006857A (he) 1970-12-04
CA931077A (en) 1973-07-31
IE34331L (en) 1970-12-02
US3678163A (en) 1972-07-18
IE34331B1 (en) 1975-04-16
FR2051568B1 (he) 1974-04-12
DE2026740A1 (de) 1970-12-10

Similar Documents

Publication Publication Date Title
KR100344479B1 (ko) 카바페넴항생물질을안정화시키는방법
RU2557910C2 (ru) Оксазолидинонсодержащие димерные соединения, композиции и способы их получения и использования
CA1336003C (en) Pentamidine salts useful in the treatment and prophylaxis of pneumocystis carinii pneumonia
ES2749053T3 (es) Polimixinas de baja sustitución y sus composiciones
Al-Juboori et al. Formulation and Evaluation of ocular in-Situ gelling system containing ciprofloxacin and Naproxen Sodium
AU612343B2 (en) A dry formulation for the preparation of a suspension of diclofenac in salt form; and a stable suspension produced therefrom
IL34552A (he) תכשירי רוקחות המכילים )-( )ציס-1,2-אפאוקסיפרופיל(- פוספונט
PT655249E (pt) Moenomicina como medicamento para o tratamento de ulceras gastricas
US2438106A (en) Peroral penicillin compositions
BG61368B2 (bg) Моно(2-амониев-2-хидроксиметил-1,3-пропандиол)(2r-сis)- (3-метоксиранил)фосфонат,получаване и фармацевтични състави,които го съдържат
ES2234569T3 (es) Uso de una composicion farmaceutica en la preparacion de un medicamento para el tratamiento de estados patologicos del ojo causados por bacterias, virus, hongos, levaduras y protozoarios.
CN102688183A (zh) 一种稳定的盐酸莫西沙星注射剂
DK175032B1 (da) Farmaceutiske præparater omfattende en vandig opløsning af et pyranoquinolinderivat
IL21955A (en) Salts of fusidic acid and antibiotics of the tetracycline series
EP2802327A1 (en) Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and method for using same
US8952164B2 (en) R-7-(3-aminomethy-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydo-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
US3322627A (en) Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
US4557932A (en) Antibacterial synergistic pharmaceutical compositions
WO2019168289A1 (ko) 벤조피란 유도체 또는 이의 약학적으로 허용가능한 염을 포함하는 용액 형태의 점안제
WO2003070231A1 (fr) Compositions antibacteriennes
US20080171766A1 (en) Novel Method
US3510544A (en) Diguaiacyl phosphate salt of tetracycline
RU2667118C1 (ru) Универсальное средство в виде мази для комплексного лечения глазных болезней животных и способ его получения
UA72286C2 (en) Alkaline salts n-(6-alkyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinsulfone)-n'-izonicotinoylhydrazide which can be used as antimicrobial and immunotropic agents, a method for the preparation thereof, use thereof as immunomodulator and pharmaceutical composition based thereon
JPH0692970A (ja) トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法